Medicalgorithmics SA
WSE:MDG
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| PL |
M
|
Medicalgorithmics SA
WSE:MDG
|
319.5m PLN |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.1B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.1B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.9B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
40.1B USD |
Loading...
|
Market Distribution
| Min | -9 940 700% |
| 30th Percentile | -3.7% |
| Median | 2.9% |
| 70th Percentile | 9.1% |
| Max | 196 605.3% |
Other Profitability Ratios
Medicalgorithmics SA
Glance View
Medicalgorithmics SA engages in the development of mobile electrocardiogram and arrhythmia diagnostic technology. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 329 full-time employees. The company went IPO on 2011-11-09. The firm develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). The company operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Medicalgorithmics SA is -57.4%, which is below its 3-year median of -26.1%.
Over the last 3 years, Medicalgorithmics SA’s Net Margin has increased from -175.3% to -57.4%. During this period, it reached a low of -175.3% on Sep 30, 2022 and a high of 32.2% on Jun 30, 2023.
